Share URL
Embed chart view
StockViz
Idorsia Ltd
Swiss Stock Exchange:IDIA.SW
Sector
Industries
Location
Market Cap
USD 664.04 M
Share Price
USD 3.26
Avg Daily Volume
1,576,858
Change (1 day)
2.25%
Change (1 year)
Change (YTD)
299.23%
Idorsia Ltd Enterprise Value to EBITDA (EV/EBITDA) on August 15, 2025: -5.43
Idorsia Ltd Enterprise Value to EBITDA (EV/EBITDA) is -5.43 on August 15, 2025. EV/EBITDA ratio compares the enterprise value to the EBITDA; lower suggests more favorable company valuation.
-
Idorsia Ltd 52-week low Enterprise Value to EBITDA (EV/EBITDA) is -4.20 on August 15, 2025, which is 22.71% above the current Enterprise Value to EBITDA (EV/EBITDA).
-
Idorsia Ltd 52-week low Enterprise Value to EBITDA (EV/EBITDA) is -6.03 on August 15, 2025, which is -10.99% below the current Enterprise Value to EBITDA (EV/EBITDA).
-
Idorsia Ltd average Enterprise Value to EBITDA (EV/EBITDA) for the last 52 weeks is -4.86.
Competitors
Eli Lilly and Company
USD 701.23
LLY
+16.80
2.46%
AbbVie Inc.
USD 206.69
ABBV
+2.01
0.98%
Roche Holding AG
USD 331.61
RO.SW
+7.43
2.29%
Novartis AG
USD 123.29
NOVN.SW
+1.51
1.24%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Novo Nordisk A/S
USD 50.97
NOVO-B.CO
+0.44
0.87%
Merck & Co., Inc.
USD 84.21
MRK
+1.45
1.75%
Thermo Fisher Scientific Inc.
USD 489.01
TMO
+3.97
0.82%
Amgen Inc.
USD 296.47
AMGN
+6.18
2.13%
Gilead Sciences, Inc.
USD 118.37
GILD
-0.65
-0.55%
Pfizer Inc.
USD 25.14
PFE
+0.03
0.12%
Sanofi
USD 99.43
SAN.PA
+2.12
2.18%
Vertex Pharmaceuticals Incorporated
USD 392.79
VRTX
+2.49
0.64%
Bristol-Myers Squibb Company
USD 48.44
BMY
+0.63
1.32%
Chugai Pharmaceutical Co., Ltd.
USD 42.42
4519.T
+0.95
2.29%
Key Data
| Date | Enterprise Value to EBITDA (EV/EBITDA) | Free Cash Flow Yield | Dividend Yield | Market Capitalization |
|---|
Competitors
Eli Lilly and Company
USD 701.23
LLY
+16.80
2.46%
AbbVie Inc.
USD 206.69
ABBV
+2.01
0.98%
Roche Holding AG
USD 331.61
RO.SW
+7.43
2.29%
Novartis AG
USD 123.29
NOVN.SW
+1.51
1.24%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Novo Nordisk A/S
USD 50.97
NOVO-B.CO
+0.44
0.87%
Merck & Co., Inc.
USD 84.21
MRK
+1.45
1.75%
Thermo Fisher Scientific Inc.
USD 489.01
TMO
+3.97
0.82%
Amgen Inc.
USD 296.47
AMGN
+6.18
2.13%
Gilead Sciences, Inc.
USD 118.37
GILD
-0.65
-0.55%
Pfizer Inc.
USD 25.14
PFE
+0.03
0.12%
Sanofi
USD 99.43
SAN.PA
+2.12
2.18%
Vertex Pharmaceuticals Incorporated
USD 392.79
VRTX
+2.49
0.64%
Bristol-Myers Squibb Company
USD 48.44
BMY
+0.63
1.32%
Chugai Pharmaceutical Co., Ltd.
USD 42.42
4519.T
+0.95
2.29%